SCHEMBL2766487

SCHEMBL2766487

COc1cc(F)c(N2CCC(C(=O)O)CC2)cc1F

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.59
ACACB O00763 1/20 0.47
NOTUM Q6P988 2/20 0.45
KDM4E B2RXH2 5/20 0.43
USP2 O75604 1/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
APEX1 P27695 1/20 0.43
NEK2 P51955 2/20 0.42
PLK1 P53350 1/20 0.42
NEK1 Q96PY6 1/20 0.42
KMT2A Q03164 3/20 0.42
GAA P10253 2/20 0.41
TDP1 Q9NUW8 2/20 0.40
MALT1 Q9UDY8 1/20 0.40
ALDH1A1 P00352 2/20 0.40
ALOX15 P16050 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2767535 0.83 HPGD (0.56) FFAR4KDM4EHPGDKMT2ATDP1
SCHEMBL2767859 0.83 FFAR4 (0.51) FFAR4ACACBKDM4EHPGDHSD17B10
SCHEMBL2768196 0.80 FFAR4 (0.51) FFAR4ACACBKDM4EKMT2AGAA
SCHEMBL13896505 0.80 NOTUM (0.53) FFAR4NOTUMAPEX1KMT2A
SCHEMBL2766678 0.79 FFAR4 (0.54) FFAR4ACACBNPSR1GAAALDH1A1
SCHEMBL29768448 0.76 MALT1 (0.49) NOTUMKDM4EUSP2HPGDNPSR1
SCHEMBL2769245 0.75 FFAR4 (0.49) FFAR4ACACBHSD17B10KMT2AALDH1A1
SCHEMBL16482930 0.74 FFAR4 (1.00) FFAR4
SCHEMBL2768381 0.74 SLC6A2 (0.55) FFAR4KMT2AALDH1A1CYP2C19
SCHEMBL2073619 0.74 NOTUM (0.56) FFAR4NOTUMKDM4EUSP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA FFAR4 2828/4885ACACB 350/4885NOTUM 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.